5,7-Diacetyl-6-(5-carboxy-7-hydroxy-4-oxochromen-3-yl)-2,3-dihydroxy-9-oxoxanthene-1-carboxylic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 5,7-Diacetyl-6-(5-carboxy-7-hydroxy-4-oxochromen-3-yl)-2,3-dihydroxy-9-oxoxanthene-1-carboxylic acid
• 化学式: C₂₈H₁₆O₁₃
• 分子量: 560.4
• InChiKey: YERVQFCNLIUOQB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  41
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  222
• 氢给体数：
  5
• 氢受体数：
  13

文献信息

• ANALOGS OF VINAXANTHONE AND XANTHOFULVIN, METHODS OF SYNTHESIS, AND METHODS OF TREATMENTS THEREOF
  申请人：BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

  公开号：US20160185745A1

  公开（公告）日：2016-06-30

  The present invention relates generally to methods of synthesis of vinaxanthone and xanthofulvin, novel analogs, and methods of use thereof.

  本发明涉及文纳黄酮和黄傅素的合成方法，新的类似物及其使用方法。
• Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
  申请人：Kimura Toru

  公开号：US20070015820A1

  公开（公告）日：2007-01-18

  To provide a semaphorin inhibitor; a peripheral or central nerve regeneration promoter which contains said semaphorin inhibitor as an active ingredient; and a preventive or remedy for a neuropathic disease and a neurodegenerative disease containing said nerve regeneration promoter, or the like. A low-molecular weight compound, which acts at a concentration of 10 μg/ml or below to inhibit the growth cone collapse activity of semaphorin such as semaphorin 3A, semaphorin 6C or the like and/or the nerve outgrowth inhibitory activity of semaphorin in a collagen gel and which does not substantially affect cell proliferation, is obtained from the culture of strain SPF-3059 belonging to the genus Penicillium. The low-molecular weight compound with the semaphorin inhibitory activity thus obtained exhibits the in vivo nerve-regeneration promoting action.
• THERAPEUTIC AGENT FOR CORNEAL SENSORY NERVE DAMAGE CONTAINING SEMAPHORIN INHIBITOR AS ACTIVE INGREDIENT
  申请人：Okano Hideyuki

  公开号：US20140018416A1

  公开（公告）日：2014-01-16

  A compound represented by formula (1), or a pharmaceutically acceptable salt thereof is effective as a therapeutic agent or a prophylactic agent for a corneal disease or sensory nerve damage due to corneal surgery, and as a regeneration accelerator for corneal sensory nerves: wherein R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxy group, R 3 represents a hydrogen atom or a carboxyl group, and R 4 represents a hydrogen atom or a hydroxy group.
• US7244761B2
  申请人：——

  公开号：US7244761B2

  公开（公告）日：2007-07-17
• US7317038B2
  申请人：——

  公开号：US7317038B2

  公开（公告）日：2008-01-08